XML 25 R4.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Thousands, $ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 746,724 $ 613,110
Trade accounts receivable, less allowance for doubtful accounts (2020—$2,083; 2019—$3,711) 530,838 612,651
Other accounts receivable 61,958 67,551
Inventories 750,237 768,984
Other current assets 116,427 162,813
Total current assets 2,206,184 2,225,109
Property, plant and equipment, at cost 7,427,641 6,817,843
Less accumulated depreciation and amortization 2,073,016 1,908,370
Net property, plant and equipment 5,354,625 4,909,473
Investments 656,244 579,813
Other assets 219,268 213,061
Goodwill 1,665,520 1,578,785
Other intangibles, net of amortization 349,105 354,622
Total assets 10,450,946 9,860,863
Current liabilities:    
Accounts payable 483,221 574,138
Accrued expenses 440,763 576,297
Current portion of long-term debt 804,677 187,336
Dividends payable 40,937 38,764
Income taxes payable 32,251 32,461
Total current liabilities 1,801,849 1,408,996
Long-term debt 2,767,381 2,862,921
Postretirement benefits 48,075 50,899
Pension benefits 340,818 292,073
Other noncurrent liabilities 629,377 754,536
Deferred income taxes 394,852 397,858
Commitments and contingencies
Common Stock, Shares, Issued 106,842 106,040
Common Stock, Shares Authorized 150,000 150,000
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Albemarle Corporation shareholders’ equity:    
Common stock, $.01 par value (authorized 150,000 shares), issued and outstanding — 106,842 in 2020 and 106,040 in 2019 $ 1,069 $ 1,061
Additional paid-in capital 1,438,038 1,383,446
Accumulated other comprehensive loss (326,132) (395,735)
Retained earnings 3,155,252 2,943,478
Total Albemarle Corporation shareholders’ equity 4,268,227 3,932,250
Noncontrolling interests 200,367 161,330
Total equity 4,468,594 4,093,580
Total liabilities and equity $ 10,450,946 $ 9,860,863